GSDME and neoplasm: Importantly, HMGB1 release and GSDME cleavage were observed upon the challenge of these ORFV recombinants, further confirmed the ability of these ORFV recombinants on triggering tumor cell pyroptosis (Supplementary Fig. 3b).